Our top pick for
Synovus Financial Corp is a banks-regional business based in the US. Synovus Financial shares (SNV) are listed on the NYSE and all prices are listed in US Dollars. Synovus Financial employs 4,983 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$49.40|
|52-week range||$23.05 - $49.74|
|50-day moving average||$42.87|
|200-day moving average||$44.67|
|Wall St. target price||$52.34|
|Dividend yield||$1.32 (2.9%)|
|Earnings per share (TTM)||$3.90|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||8.64%|
|1 month (2021-09-21)||26.89%|
|3 months (2021-07-21)||16.98%|
|6 months (2021-04-21)||7.55%|
|1 year (2020-10-21)||97.92%|
|2 years (2019-10-21)||36.28%|
|3 years (2018-10-19)||17.68%|
|5 years (2016-10-21)||49.97%|
Valuing Synovus Financial stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Synovus Financial's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Synovus Financial's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Synovus Financial shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Synovus Financial's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.34. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Synovus Financial's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$2 billion|
|Operating margin TTM||45.99%|
|Gross profit TTM||$1.7 billion|
|Return on assets TTM||1.13%|
|Return on equity TTM||11.96%|
|Market capitalisation||$6.7 billion|
TTM: trailing 12 months
There are currently 2.2 million Synovus Financial shares held short by investors – that's known as Synovus Financial's "short interest". This figure is 5.7% up from 2.1 million last month.
There are a few different ways that this level of interest in shorting Synovus Financial shares can be evaluated.
Synovus Financial's "short interest ratio" (SIR) is the quantity of Synovus Financial shares currently shorted divided by the average quantity of Synovus Financial shares traded daily (recently around 1.0 million). Synovus Financial's SIR currently stands at 2.14. In other words for every 100,000 Synovus Financial shares traded daily on the market, roughly 2140 shares are currently held short.
However Synovus Financial's short interest can also be evaluated against the total number of Synovus Financial shares, or, against the total number of tradable Synovus Financial shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Synovus Financial's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Synovus Financial shares in existence, roughly 20 shares are currently held short) or 0.0155% of the tradable shares (for every 100,000 tradable Synovus Financial shares, roughly 16 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Synovus Financial.
Find out more about how you can short Synovus Financial stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Synovus Financial.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 33.33
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Synovus Financial's overall score of 33.33 (as at 12/31/2018) is nothing to write home about – landing it in it in the 49th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Synovus Financial is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 9.82/100
Synovus Financial's environmental score of 9.82 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Synovus Financial is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 16.79/100
Synovus Financial's social score of 16.79 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Synovus Financial is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 19.72/100
Synovus Financial's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Synovus Financial is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Synovus Financial scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Synovus Financial has, for the most part, managed to keep its nose clean.
|Total ESG score||33.33|
|Total ESG percentile||49.28|
|Environmental score percentile||9|
|Social score percentile||9|
|Governance score percentile||9|
|Level of controversy||2|
Dividend payout ratio: 30.14% of net profits
Recently Synovus Financial has paid out, on average, around 30.14% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.89% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Synovus Financial shareholders could enjoy a 2.89% return on their shares, in the form of dividend payments. In Synovus Financial's case, that would currently equate to about $1.32 per share.
While Synovus Financial's payout ratio might seem fairly standard, it's worth remembering that Synovus Financial may be investing much of the rest of its net profits in future growth.
Synovus Financial's most recent dividend payout was on 30 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 September 2021 (the "ex-dividend date").
Synovus Financial's shares were split on a 1:7 basis on 18 May 2014. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Synovus Financial shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Synovus Financial shares which in turn could have impacted Synovus Financial's share price.
Over the last 12 months, Synovus Financial's shares have ranged in value from as little as $23.0538 up to $49.7372. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Synovus Financial's is 1.582. This would suggest that Synovus Financial's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Synovus Financial Corp. operates as the bank holding company for Synovus Bank that provides commercial and retail banking products and services. It operates through three segments: Community Banking, Wholesale Banking, and Financial Management Services. The company's commercial banking services include treasury management, asset management, capital market, and institutional trust services, as well as commercial, financial, and real estate loans. Its retail banking services comprise accepting customary types of demand and savings deposits accounts; mortgage, installment, and other consumer loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; Internet-based banking services; and bank credit and debit card services. The company also offers various other financial services, including portfolio management for fixed-income securities, investment banking, execution of securities transactions as a broker/dealer, and financial planning services, as well as provides individual investment advice on equity and other securities. As of December 31, 2020, it operated through 289 branches and 389 ATMs in Alabama, Florida, Georgia, South Carolina, and Tennessee.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.